NRX PHARMACEUTICALS INC's ticker is and the CUSIP is 629444900. A total of 3 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -46.2% | 27,800 | -3.1% | 0.00% | – |
| Q2 2023 | $13 | -31.6% | 28,700 | -2.4% | 0.00% | – |
| Q1 2023 | $19 | -20.8% | 29,400 | +30.7% | 0.00% | – |
| Q4 2022 | $24 | -99.4% | 22,500 | +294.7% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 5,700 | +35.7% | 0.00% | – |
| Q2 2022 | $2,000 | -80.0% | 4,200 | -4.5% | 0.00% | – |
| Q1 2022 | $10,000 | -86.5% | 4,400 | -71.6% | 0.00% | – |
| Q4 2021 | $74,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 104,500 | $63,000 | 0.00% |
| SIMPLEX TRADING, LLC | 4,200 | $2,000 | 0.00% |